1 not yet recruiting, 1 recruiting. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Adimanebart IV: new trials by email Literature Review of Adimanebart IV trials Research Report on Adimanebart IV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Efficacy and Safety of Adimanebart in Adult and Pediatric Participants With DOK7-,MUSK-, AGRN-, or LRP4- Congenital Myasthenic Syndromes (CMS) Adimanebart IV, Placebo IV - Congenital Myasthenic Syndrome, CMS | Phase 3 | Not yet recruiting | argenx | 105 | 2026-09-01 | 2026-10-19 |
| A Study to Assess the Absolute Bioavailability and How Adimanebart SC Moves Through the Body in Healthy Adult Participants Adimanebart IV, Adimanebart SC - formulation A, Adimanebart SC - formulation B - Healthy Volunteers (HV), Healthy Volunteer | Phase 1 | Recruiting | argenx | 52 | 2026-06-12 | 2026-06-29 |
Myasthenic Syndromes, Congenital (1)
argenx (2)
Canada (1)
2025 (1)